Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014679 |
| CAS No | NA |
| Mol.F. | C8H15N8O3S3 |
| Mol.Wt. | 367.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014680 |
| CAS No | NA |
| Mol.F. | C7H5N3OS |
| Mol.Wt. | 179.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014681 |
| CAS No | NA |
| Mol.F. | C18H20N4O3S |
| Mol.Wt. | 372.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014682 |
| CAS No | NA |
| Mol.F. | C18H20N4O4S |
| Mol.Wt. | 388.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014683 |
| CAS No | NA |
| Mol.F. | C25H29N3O6 |
| Mol.Wt. | 467.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014684 |
| CAS No | 2380680-64-6 |
| Mol.F. | C5H10N2O2 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014685 |
| CAS No | NA |
| Mol.F. | C20H18N2O |
| Mol.Wt. | 302.38 |
| INV STATUS | In Stock |
| CAT No | SRC-N014686 |
| CAS No | 64091-91-4 |
| Mol.F. | C10H13N3O2 |
| Mol.Wt. | 207.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014687 |
| CAS No | 61601-78-3 |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014688 |
| CAS No | 71267-22-6 |
| Mol.F. | C10H11N3O |
| Mol.Wt. | 189.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014689 |
| CAS No | 1133-64-8 |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014690 |
| CAS No | NA |
| Mol.F. | C16H16N2O2 |
| Mol.Wt. | 268.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014691 |
| CAS No | 2657645-00-4 |
| Mol.F. | C17H18FN3O3 |
| Mol.Wt. | 331.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014692 |
| CAS No | NA |
| Mol.F. | C16H19N5O4S |
| Mol.Wt. | 377.42 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014693 |
| CAS No | 3036581-86-6 |
| Mol.F. | C13H18N4O3S |
| Mol.Wt. | 310.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014694 |
| CAS No | NA |
| Mol.F. | C21H42N6O8 |
| Mol.Wt. | 506.6 |
| INV STATUS | CUSTOM SYNTHESIS |